PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients. (April 2016) - De Colle, C.; Menegakis, A.; Mueller, A.C.; Yaromina, A.; Hennenlotter, J.; Stenzl, A.; Scharpf, M.; Fend, F.; Ricardi, U.; Baumann, M.; Zips, D.